← Back to all trials
Completed
NCT06826742
Intravenous Methadone Versus Intrathecal Morphine for Analgesia Following Cesarean Delivery
Conditions: Cesarean Delivery
Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: PHASE4
Enrollment: 30
Sponsor: Mayo Clinic
Location: Mayo Clinic in Rochester Rochester Minnesota
Summary
The purpose of this study is to determine if there is a difference in opioid requirements at 0-48 hours after scheduled cesarean delivery in patients receiving 150 mcg intrathecal morphine compared to 0.2 mg/kg (maximum 20 mg) intravenous methadone.
Eligibility Criteria
Inclusion Criteria:
* English-speaking
* Age over 18 years old
* Scheduled cesarean delivery
Exclusion Criteria:
* Any contraindication to the administration of a spinal technique for anesthesia
* History of intolerance or adverse reaction to opioid medications
* History of chronic pain, opioid use \>30 OME/day, or substance use disorder
* History of obstructive sleep apnea, chronic obstructive pulmonary disease, or respiratory compromise (SpO2 \50.0 kg/m2
* ASA status IV, V
* No prior history of an ECG demonstrating QTc \> 440ms
* Surgical complication requiring conversion to general anesthesia
Source: ClinicalTrials.gov (NCT06826742). StuddyBuddy aggregates publicly available trial information.